Tvardi Therapeutics, Inc. (TVRD)

NASDAQ: TVRD · Real-Time Price · USD

1.860

-0.040 (-2.11%)

At close: Aug 17, 2026, 4:00 PM EDT

1.950

+0.090 (4.84%)

Pre-market: Aug 18, 2026, 8:04 AM EDT

Tvardi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	17	40	-	-	-
Market Cap Growth	-92.14%	-	-	-	-
Enterprise Value	2	4	-	-	-
Last Close Price	1.86	4.30	-	-	-
PB Ratio	2.08	1.93	-	-	-
P/TBV Ratio	2.16	1.96	-	-	-
Debt / Equity Ratio	0.02	0.01	-5.43	0.02	0.01
Net Debt / Equity Ratio	-1.86	-1.46	0.19	-0.96	-1.07
Net Debt / EBITDA Ratio	0.58	1.15	0.04	1.21	2.05
Net Debt / FCF Ratio	0.62	1.30	0.06	1.07	2.42
Quick Ratio	1.73	2.79	3.05	6.99	10.23
Current Ratio	1.87	2.86	3.06	7.97	10.31
Return on Equity (ROE)	-126.18%	-237.81%	-329.99%	-54.30%	-
Return on Assets (ROA)	-55.51%	-49.70%	-56.48%	-32.36%	-
Return on Capital Employed (ROCE)	-323.70%	-127.20%	-113.20%	-78.70%	-51.90%
Earnings Yield	-149.36%	-45.15%	-	-	-
FCF Yield	-143.44%	-58.25%	-	-	-
Buyback Yield / Dilution	-134.87%	-202.35%	59.64%	-0.09%	-

SEC Filings: 10-K · 10-Q